Calithera Biosciences, Inc.
CALA · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $5 | $6 | $8 | $10 |
| G&A Expenses | $3 | $3 | $4 | $4 |
| SG&A Expenses | $3 | $3 | $4 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $7 | $10 | $11 | $14 |
| Operating Income | -$7 | -$10 | -$11 | -$14 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | -$0 | $2 | -$0 |
| Pre-Tax Income | -$7 | -$10 | -$9 | -$14 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7 | -$10 | $10 | -$14 |
| % Margin | – | – | – | – |
| EPS | -1.42 | -2.01 | 1.79 | -3.53 |
| % Growth | 29.4% | -212.3% | 150.7% | – |
| EPS Diluted | -1.42 | -2.01 | 1.79 | -3.53 |
| Weighted Avg Shares Out | 5 | 5 | 6 | 4 |
| Weighted Avg Shares Out Dil | 5 | 5 | 6 | 4 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | -$2 | $0 |
| EBITDA | -$7 | -$9 | -$11 | -$14 |
| % Margin | – | – | – | – |